LONDON, ONTARIO -- (MARKET WIRE) -- December 27, 2006 -- Stellar Pharmaceuticals Inc. ("Stellar" or "the Company")(TSX VENTURE: SLX)(OTCBB: SLXCF) is pleased to announce that it has entered into an investor relations agreement (the "Agreement") with Seventh Circle Consulting, LLC ("Seventh Circle") pursuant to which the Company will engage Seventh Circle to provide certain investor relations services for an initial period of two months.
